A detailed history of Charles Schwab Investment Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,574,572 shares of EW stock, worth $330 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,574,572
Previous 3,448,854 3.65%
Holding current value
$330 Million
Previous $263 Million 29.89%
% of portfolio
0.08%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$72.54 - $95.56 $9.12 Million - $12 Million
125,718 Added 3.65%
3,574,572 $342 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $349,833 - $440,821
5,669 Added 0.16%
3,448,854 $263 Million
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $7.23 Million - $9.75 Million
104,382 Added 3.13%
3,443,185 $239 Million
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $526,478 - $610,032
6,467 Added 0.19%
3,338,803 $315 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $4.63 Million - $5.27 Million
62,350 Added 1.91%
3,332,336 $276 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $8.37 Million - $10.7 Million
122,607 Added 3.9%
3,269,986 $244 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $763,487 - $994,471
-9,269 Reduced 0.29%
3,147,379 $260 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $4.46 Million - $6.61 Million
51,520 Added 1.66%
3,156,648 $300 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $8.25 Million - $10.4 Million
80,881 Added 2.67%
3,105,128 $366 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $9.1 Million - $11.2 Million
85,550 Added 2.91%
3,024,247 $392 Million
Q3 2021

Nov 16, 2021

BUY
$102.91 - $122.75 $6.15 Million - $7.34 Million
59,772 Added 2.08%
2,938,697 $333 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $1.54 Million - $1.93 Million
18,383 Added 0.64%
2,878,925 $298 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $20.4 Million - $23.5 Million
-259,457 Reduced 8.32%
2,860,542 $239 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $17.2 Million - $21.8 Million
-239,279 Reduced 7.12%
3,119,999 $285 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $4.37 Million - $5.68 Million
-64,985 Reduced 1.9%
3,359,278 $268 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $135 Million - $180 Million
2,339,683 Added 215.72%
3,424,263 $237 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $1.12 Million - $1.73 Million
21,363 Added 2.01%
1,084,580 $205 Million
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $5.72 Million - $6.55 Million
79,745 Added 8.11%
1,063,217 $248 Million
Q3 2019

Nov 08, 2019

BUY
$61.55 - $75.43 $1.32 Million - $1.62 Million
21,523 Added 2.24%
983,472 $216 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $1.25 Million - $1.45 Million
-22,470 Reduced 2.28%
961,949 $178 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $7.22 Million - $9.65 Million
150,727 Added 18.08%
984,419 $188 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $961,847 - $1.18 Million
20,725 Added 2.55%
833,692 $128 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $836,310 - $1.06 Million
18,300 Added 2.3%
812,967 $142 Million
Q2 2018

Aug 08, 2018

BUY
$42.45 - $51.3 $1.12 Million - $1.35 Million
26,346 Added 3.43%
794,667 $116 Million
Q1 2018

May 07, 2018

BUY
$37.19 - $47.45 $1.65 Million - $2.11 Million
44,489 Added 6.15%
768,321 $107 Million
Q4 2017

Jan 17, 2018

BUY
$33.79 - $39.39 $973,861 - $1.14 Million
28,821 Added 4.15%
723,832 $81.6 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $25.2 Million - $27 Million
695,011
695,011 $76 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.